The softer sales, along with reimbursement pressure in wound care, caused the London-based company to miss Wall Street ...

Cochlear completes pivotal trial enrollment for its fully implantable hearing device. CTO shares insights on design, safety, ...

Guardant Health's Shield blood test wins the 2026 Prix Galien USA Award for Best Medical Technology, recognizing its impact ...

Boston Scientific's SIMPLAAFY data show aspirin alone or reduced-dose anticoagulation matches DAPT after Watchman Flx Pro ...

Few medtech firms use FDA's PCCP pathway because most lack the MLOps infrastructure needed to safely iterate AI models ...

Explore questions and considerations that come into play when moving an additive application from design freeze toward ...

Boston Scientific cuts Q4 guidance as cyberattack fallout and EP and Watchman market pressures weigh on growth heading into ...

Edwards' PROGRESS Trial found TAVR cut death or heart failure risk by a third versus surveillance in moderate aortic stenosis patients at TCT 2026.

Stryker lowered its 2026 sales and EPS guidance after a Q3 miss, citing slowing joint replacement demand and ...

Dexcom's landmark CONNECT trial, now published in the NEJM, could drive a pivotal CMS coverage decision for type 2 diabetes patients this year.

Senseonics has begun human testing of Freedom, a CGM designed to eliminate the on-body transmitter, with COO Mukul Jain ...

Dyconex created a biocompatible PCB platform that shrinks medical device interconnects while boosting functionality and ...